Barriers to accessing biologic treatment for rheumatoid arthritis in Greece: the unseen impact of the fiscal crisis–the Health Outcomes Patient Environment (HOPE) studyRheumatology InternationalFebruary 7, 2026
Healthcare access for cancer patients in the era of economic crisis. Results from the HOPE III studyForum of Clinical OncologyFebruary 7, 2026
Access to Care for Multiple Sclerosis in Times of Economic Crisis in Greece–the HOPE II StudyInternational Journal of Health Policy and ManagementFebruary 7, 2026
Access to treatment for Hepatitis C among injection drug users: results from the cross-sectional HOPE IV studyInternational Journal for Equity in HealthFebruary 7, 2026
Health Democracy Index: Development and Validation of a Self-Reported Instrument for Measuring Patient Participation in Health PolicyFrontiers in Public HealthFebruary 7, 2026
Real world, big data cost of pharmaceutical treatment for rheumatoid arthritis in GreecePLoS OneFebruary 7, 2026
Profile and factors associated with glycaemic control of patients with type 2 diabetes in Greece: results from the diabetes registryBMC Endocrine DisordersFebruary 7, 2026
Access to health care for patients with thalassaemia in Greece: a cross-sectional studyEastern Mediterranean Health JournalFebruary 7, 2026
Public Health Behaviors during the COVID-19 Pandemic in Greece and Associated Factors: A Nationwide Cross-sectional Survey””InquiryFebruary 7, 2026
